Newlink Genetics reported 7.84M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 61.4M 12.89M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Capricor Therapeutics CAPR:US $ 7.83M 1.44M
Celldex Therapeutics CLDX:US $ 23.43M 2.76M
Eli Lilly And LLY:US $ 5405.7M 677M
Idera Pharmaceuticals IDRA:US $ 4.18M 61K
Intrexon XON:US $ 49.92M 5.21M
Merk MRK:US $ 10332M 386M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Newlink Genetics NLNK:US 7.84M 1.05M
Pfizer PFE:US $ 15788M 3271M
Prothena PRTA:US 39.1M 4.83M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Vascular Biogenics VBLT:US 10.68M 1.37M
YTE INCY:US $ 616.69M 135.42M